Drugmaker Says 11th Circ. Ruling Based On 'Straw Man'
The maker of a drug for pediatric patients with a rare autoimmune disease told the Eleventh Circuit it must reconsider a panel ruling in favor of its rival Catalyst Pharmaceuticals Inc....To view the full article, register now.
Already a subscriber? Click here to view full article